Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population

Molecular Carcinogenesis

Volumn 49, Issue 7, 2010, Pages 684-692

  Srivastava, Kshitij ^a   Srivastava, Anvesha ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Caspase 8; Epidemiology; Gallbladder cancer; Polymorphism; RFLP

Indexed keywords

CASPASE 8;

ADULT; AGED; APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER; GALLSTONE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR MODEL; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL ANALYSIS;

ADULT; AGED; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CASPASE 8; FEMALE; GALLBLADDER NEOPLASMS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDIA; MALE; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 77954471086     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20641     Document Type: Article

References (37)

1. Randi G, MalvezziM, Levi F, et al. Epidemiology of biliary tract cancers: An update. Ann Oncol 2009;20:146-159.
2. Hsing AW, Gao YT, Han TQ, et al. Gallstones and the risk of biliary tract cancer: A population-based study in China. Br J Cancer 2007;97:1577-1582. (Pubitemid 350175843)
3. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-776.
4. Siegel RM. Caspases at the crossroads of immune cell life and death. Nat Rev Immunol 2006;6:308-317.
5. Shin MS, Kim HS, Kang CS, et al. Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 2002;99:4094-4099. (Pubitemid 35332052)
6. Soung YH, Lee JW, Kim HS, et al. Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene 2003;22:8048-8052.
7. Soung YH, Lee JW, Kim SY, et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005;65:815-821.
8. Soung YH, Lee JW, Kim SY, et al. Somatic mutations of CASP3 gene in human cancers. Hum Genet 2004;115:112-115. (Pubitemid 39010925)
9. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 1997;186:785-793.
10. Sobin LH, Wittekind CH, editors. International Union Against Cancer (UICC): TNM classification of malignant tumours, 6th edition. New York: Wiley-Liss; 2002, pp 184-187.
11. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55:997-1004.
12. Son JW, Kang HK, Chae MH, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 2006;169:121-127.
13. Hu Z, Li C, Chen K, et al. Single nucleotide polymorphisms in selected apoptotic genes and BPDE-induced apoptotic capacity in apparently normal primary lymphocytes: A genotype-phenotype correlation analysis. J Cancer Epidemiol 2008;2008:8.
14. Wang J, Shete S. A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases. Am J Hum Genet 2008;83:53-63.
15. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1995;11:375-386.
16. Brennan P. Gene-environment interaction and aetiology of cancer: What does it mean and how can we measure it? Carcinogenesis 2002;23:381-387.
17. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. Br Med J 1995;311:1145-1148.
18. Abecasis GR, Cookson WOC. GOLD - Graphical overview of linkage disequilibrium. Bioinformatics 2000;16:182-183.
19. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-442. (Pubitemid 38443646)
20. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001;11:863-874.
21. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 2002;30:3894-3900. (Pubitemid 35012462)
22. Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 2004;83:970-979.
23. Kelley LA, MacCallum RM, Sternberg MJ. Enhanced genome annotation using structural profiles in the program 3DPSSM. J Mol Biol 2000;299:499-520.
24. Sali A, Potterton L, Yuan F, van Vlijmen H, Karplus M. Evaluation of comparative protein modeling by MODELLER. Proteins 1995;23:318-326.
25. Wiederstein M, Sippl MJ. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:W407-W410.
26. Hamajima N, Yuasa H, Matsuo K, Kurobe Y. Detection of gene-environment interaction by case-only studies. Jpn J Clin Oncol 1999;29:490-493.
27. Yang Q, Khoury MJ. Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997;19:33-43.
28. Hsing AW, Sakoda LC, Rashid A, et al. Variants in inflammation genes and the risk of biliary tract cancers and stones: A population-based study in China. Cancer Res 2008;68:6442-6452.
29. Srivastava A, Srivastava K, Pandey S, Choudhuri G, Mittal B. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: Association with gallbladder cancer in North Indian population. Ann Surg Oncol 2009;16:1695-1703.
30. Srivastava K, Srivastava A, Pandey S, Kumar A, Mittal B. Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population. J Gastroenterol 2009;44:774-780.
31. Sun T, Gao Y, Tan W, et al. Asix-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 2007;39:605-613.
32. Frank B, Rigas SH, Bermejo JL, et al. The CASP 8-652 6N del promoter polymorphism and breast cancer risk: A multicenter study. Breast Cancer Res Treat 2008;111:139-144.
33. Bethke L, Sullivan K, Webb E, et al. CASP8 D302H and meningioma risk: An analysis of five case-control series. Cancer Lett 2009;273:312-315.
34. Cox A, Dunning AM, Garcia-Closas M, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007;39:352-358.
35. Bethke L, Sullivan K, Webb E, et al. The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev 2008;17:987-989.
36. Diehl AK. Gallstone size and the risk of gallbladder cancer. J Am Med Assoc 1983;250:2323-2326.
37. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001;51:349-364.